PEN Q3 2023 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$271M+26.8% YoY

Gross Profit

$178M65.6% margin

Operating Income

$13M4.7% margin

Net Income

$9M3.4% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$28M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$364M

Stockholders' Equity

$1.1B

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$271M	$214M	+26.8%
Gross Profit	$178M	$135M	+31.3%
Operating Income	$13M	$5M	+132.3%
Net Income	$9M	-$2M	+505.7%

Revenue Segments

Neuro

$171M63%

Peripheral Vascular

$100M37%

Geographic Segments

UNITED STATES

$195M72%

Other Non-US

$76M28%